Benzinga | Sep 24, 2020 08:35AM EDT

Dexcom Signs Multi-Year Collaboration Agreement With The University Of Virginia To Advance Type 1 And Type 2 Diabetes Research

DexCom, Inc. (NASDAQ:DXCM) today announced it has signed a five-year collaboration agreement with the University of Virginia to advance its research and development efforts on continuous glucose monitoring-based solutions. The research partnership will center on advancing Dexcom's automated insulin delivery technology and exploring the use of continuous glucose monitoring tools outside the Type 1 diabetes market, including inpatient hospital use, Type 2 diabetes and gestational diabetes.